ConductScience.org, home

Paper39770531

Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging Targets.

Lee H and 6 others. Pharmaceuticals (Basel), 2024. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging Targets. Papers, record 39770531. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39770531

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging Targets.
PubMed
Journal
Pharmaceuticals (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
2.67, provisional
iCite
Revised in PubMed
2025-01-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee HHwayoung
2Elkamhawy AAhmedhttps://orcid.org/0000-0001-7398-6155
3Rakhalskaya PPolinahttps://orcid.org/0009-0001-5842-4928
4Lu QQili
5Nada HHossamhttps://orcid.org/0000-0002-4882-5621
6Quan GGuofeng
7Lee KKyeong

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References106

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127486710Genetics of Parkinson's disease: a review of SNCA and LRRK2.Wiad Lek2016https://conductscience.org/library/papers/27486710PubMed
232584021General Aggregation-Induced Emission Probes for Amyloid Inhibitors with Dual Inhibition Capacity against Amyloid β-Protein and α-Synuclein.ACS Appl Mater Interfaces2020https://conductscience.org/library/papers/32584021PubMed
333432241Reverse engineering Lewy bodies: how far have we come and how far can we go?Nat Rev Neurosci2021https://conductscience.org/library/papers/33432241PubMed
411701750Adenosine in the central nervous system: release mechanisms and extracellular concentrations.J Neurochem2001https://conductscience.org/library/papers/11701750PubMed
524354345Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.J Med Chem2014https://conductscience.org/library/papers/24354345PubMed
624756517Pharmacological treatment of Parkinson disease: a review.JAMA2014https://conductscience.org/library/papers/24756517PubMed
721724302Dopaminergic agonists in Parkinson's disease.Neurologia2014https://conductscience.org/library/papers/21724302PubMed
828353284Models of LRRK2-Associated Parkinson's Disease.Adv Neurobiol2017https://conductscience.org/library/papers/28353284PubMed
920082977Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.Parkinsonism Relat Disord2009https://conductscience.org/library/papers/20082977PubMed
1037312864Novel C-Linked Isoquinoline Amides as LRRK2 Inhibitors for Treating Parkinson's Disease.ACS Med Chem Lett2023https://conductscience.org/library/papers/37312864PubMed
1130160213Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside.Curr Neuropharmacol2019https://conductscience.org/library/papers/30160213PubMed
1230982161Targeting α-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics.Drugs2019https://conductscience.org/library/papers/30982161PubMed
1333197196Selective Inhibitors of G2019S-LRRK2 Kinase Activity.J Med Chem2020https://conductscience.org/library/papers/33197196PubMed
1433219714The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease.Mov Disord2021https://conductscience.org/library/papers/33219714PubMed
1535455941GBA Variants and Parkinson Disease: Mechanisms and Treatments.Cells2022https://conductscience.org/library/papers/35455941PubMed
1616944356Ergoline and non-ergoline derivatives in the treatment of Parkinson's disease.J Neurol2006https://conductscience.org/library/papers/16944356PubMed
1733721670Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems.Eur J Med Chem2021https://conductscience.org/library/papers/33721670PubMed
1837147404Parkinson's disease therapy: what lies ahead?J Neural Transm (Vienna)2023https://conductscience.org/library/papers/37147404PubMed
1935675433Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.Sci Transl Med2022https://conductscience.org/library/papers/35675433PubMed
2030023743Biological and Pharmacological Characterization of Benzothiazole-Based CK-1δ Inhibitors in Models of Parkinson's Disease.ACS Omega2017https://conductscience.org/library/papers/30023743PubMed

See all 106 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42890068
Integrated Experimental and Computational Investigation of Fluorinated Benzoylthiourea Derivatives: Structural Characterization, Hirshfeld Surface Analysis, Antioxidant Activity, and MAO-B Inhibitory Potential for Parkinson's Disease.
ACS Omega2026https://conductscience.org/library/papers/42890068PubMed
42879042β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism.Mol Neurobiol2026https://conductscience.org/library/papers/42879042PubMed
42451623Bioanalytical HPLC-UV Determination of Dopamine in Plasma and Mouse Brain Homogenate with Greenness, Whiteness, and Blueness Assessment.Molecules2026https://conductscience.org/library/papers/42451623PubMed
42193194Overcoming Oxidative Stress in Parkinson's Disease: NADPH Oxidase 4 (NOX4) as a Potential Therapeutic Target.Antioxidants (Basel)2026https://conductscience.org/library/papers/42193194PubMed
41991085DYRK1A and Parkinson's disease, facts and hypotheses.Neurobiol Dis2026https://conductscience.org/library/papers/41991085PubMed
41516146Dopamine and the Gut Microbiota: Interactions Within the Microbiota-Gut-Brain Axis and Therapeutic Perspectives.Int J Mol Sci2025https://conductscience.org/library/papers/41516146PubMed
41462616MQPD: An Antioxidant Quinone-Dopamine Hybrid Which Induces Sustained Brain Dopamine Elevation.Antioxidants (Basel)2025https://conductscience.org/library/papers/41462616PubMed
41153773Exploring Cannabidiol's Role in Regenerative Medicine: Focus on Neural and Skeletal Tissues.Biomedicines2025https://conductscience.org/library/papers/41153773PubMed
41097126Lactiplantibacillus plantarum as a Psychobiotic Strategy Targeting Parkinson's Disease: A Review and Mechanistic Insights.Nutrients2025https://conductscience.org/library/papers/41097126PubMed
41017678Immune dysregulation and gut microbiota: Connection to health and disease development.Neural Regen Res2026https://conductscience.org/library/papers/41017678PubMed
40808332Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives.CNS Neurosci Ther2025https://conductscience.org/library/papers/40808332PubMed
40564183Next-Generation Drug Delivery for Neurotherapeutics: The Promise of Stimuli-Triggered Nanocarriers.Biomedicines2025https://conductscience.org/library/papers/40564183PubMed
40255917Dysregulation of Astrocytic ATP/Adenosine Release in the Hippocampus Cause Cognitive and Affective Disorders: Molecular Mechanisms, Diagnosis, and Therapy.MedComm (2020)2025https://conductscience.org/library/papers/40255917PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39770531

GET https://conductscience.org/api/papers/v1/39770531/references?page=2